AAVantgarde Bio
Focus: AAVantgarde Bio is an Italian biotech company developing AAV-based gene therapies focused on inherited retinal diseases, currently in early clinical stages with two Phase 1/2 programs.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at AAVantgarde Bio?
AI assessmentA high-risk, early-stage gene therapy bet suitable only for mission-driven scientists willing to trade stability for ground-floor equity upside in rare disease ophthalmology.
Why Work Here
- Ground-floor opportunity at a pure-play gene therapy platform company with a focused pipeline in high-unmet-need ophthalmology indications
- Direct involvement in clinical development of novel AAV therapeutics (AAVB-039 for Stargardt Disease, AAVB-081 for Usher Syndrome Type 1B)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
An Observational Study in Children and Adults With Stargardt Disease
Stargardt DiseaseClinical Trials (1)
NCT06591806An Observational Study in Children and Adults With Stargardt Disease
N/AHelp build intelligence for AAVantgarde Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.